AzTrials
AzTrials

Osteoarthritis, KneeNCT03966248

Chinese Tuina Therapy for Treatment of Knee Osteoarthritis

A study testing Chinese Tuina therapy and Physical Manual therapy in people with Osteoarthritis, Knee, run by Beijing University of Chinese Medicine at 1 site in China.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Knee osteoarthritis (KOA) is one of the most common musculoskeletal diseases in clinic. It usually occurs in middle-aged people, especially women. An estimated lifetime risk for KOA is approximately 40% in men and 47% in women. Read more about this study

Who is it for?
Ages 40 to 75 years
Conditions the study is for
Osteoarthritis, Knee
What is being tested?
Chinese Tuina therapy and Physical Manual therapy
Type of treatment
Pill or oral medicine
Could I receive a placebo?
No, everyone receives an active treatment
How many people
140 participants
Where
1 siteChina
Study dates
19 Oct 2019to 7 Oct 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 40 to 75 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Diagnosis of KOA;
  • Age 40-75 years;
  • KL (Kellgren-Lawrence) grade Ⅱ or Ⅲ in recent 3 months;
  • NRS score of pain at least more than 4 points;
  • Single/bilateral knee pain, duration of more than 6 month; If the patient has KOA on both legs, the heavier leg is selected for study.

Who cannot join

  • Surgery history of knee or waiting for surgery (knee replacement or knee arthroscopy);
  • Knee pain caused by other diseases (such as joint bodies, severe effusion of joint cavity, infection, malignant tumors, autoimmune diseases, trauma, etc.);
  • Oral administration of hormones within 3 month, intra-articular injection within 6 months, knee injuries or open injuries within 6 months, or knee arthroscopy within 1 year.
  • Severe acute/chronic organic or mental diseases;
  • Pregnant women, pregnant and lactating women;
  • Coagulation disorders (such as hemophilia, etc.), or the skin diseases at the site of operation;
Show all 10Show fewer
  • Device support treatment after knee osteoarthritis disability;
  • Participation in another clinical study in the past 3 months;
  • History of receiving acupuncture, massage, manipulation, or any medical plaster treatment within 3 months
  • Breaks for treatment longer than 3-4 weeks depending on each circumstance or merit may be construed as non-compliance and may be excluded.

Trial locations and contacts

1 site in 1 country.

China1 site
  • Dongzhimen hospital affiliated to Bejing University of Chinese Medicine

    Beijing, Beijing Municipality

Other trials in China

About this study

Official title: Chinese Tuina (Chinese Massage and Manipulation Therapy) for KOA: A Randomized, Parallel, Physical Therapies Active Controlled Study

Knee osteoarthritis (KOA) is one of the most common musculoskeletal diseases in clinic. It usually occurs in middle-aged people, especially women. An estimated lifetime risk for KOA is approximately 40% in men and 47% in women. KOA is a chronic disease which can lead to obvious pain, joint stiffness, limitation of activity and even disability, with significant associated costs and effects on society, health systems, and individuals. Tuina therapy has been used and showed effectiveness and safety for pain relief and disability for the patients with musculoskeletal disorders for years in China. Though it is regarded that the Traditional Chinese medicine (TCM) Tuina therapy is similar to the modern manual therapies, the modalities of TCM tuina therapy are different and effect maybe equal to or more better than the modern manual therapy in clinic. However, little evidence exists that Tuina benefits the KOA. The investigators will do this in a randomized, parallel, active controlled study to observe whether TCM Tuina is more beneficial to KOA than the physical manual therapy, which has been considered an effective and standard care for KOA.

Read the detailed description

Patients will be randomly allocated to one of two groups. In the Chinese Tuina group (group CTG), patients will receive the traditional Chinese Tuina therapy (including rolling, grasping, scratching, pressing, acupressure or pushing) on the basis of KOA health education and home-exercise. Patients in the Physical Manual group (group PMG) will receive the modern physical manual therapy (including joint mobilization/manipulation, manual traction, soft tissue manipulations, passive stretching, range of motion and strength training) on the basis of KOA health education and home-exercise. Assessments will be conducted at baseline and 4 and 16 weeks after randomization.

It is expected that the interventions will alleviate the sufferings of the patient. The risks of participation are minimal. Occasionally, tuina can make people feel nauseous or experience a temporary increase in pain either during or after treatment. Rare side effects happen during and after Tuina or manual treatment.

Being tested
Chinese Tuina therapy, Physical Manual therapy
Keywords
Arthritis, Massage, Tuina, Traditional Chinese medicine, Physical therapy, Joint Diseases, Musculoskeletal Diseases, Rheumatic Diseases, manual therapy
Medical subject headings
Osteoarthritis, Knee, Arthritis, Joint Diseases, Musculoskeletal Diseases, Rheumatic Diseases

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Chinese Tuina therapyOther

    1. The doctor presses the affected lower limb from the anterior superior iliac spine to the ankle;
    2. The doctor gives the pressure on the Biguan(ST31), Futu(ST32), Heding(EX-LE2), Neixiyan(EX-LE4), Waixiyan(Dubi, ST35), Zusanli(ST36) and Sanyinjiao(SP6) of the affected lower limb;
    3. Massage the spleen and stomach meridians of the affected lower extremes;
    4. Roll the soft tissues around the affected knee;
    5. Relax the gastrocnalis muscle
    6. The doctor gives the pressure on the Xuehai(SP10), Liangqiu(ST34), Neixifeng(medial patellofemoral ligament), Waixifeng(lateral patellofemoral ligament), Neixiyan(EX-LE4) and Waixiyan(Dubi, ST35) at the same time;
    7. Push the patella and do the passive movement of the affected knee;
    8. Strength training of the affected knee.

    This group receives 8 treatments over a 3 week period with a one week follow-up on site and a 3 month follow-up by mail, phone or email.

  • Physical Manual therapyOther

    1. Manual therapy: Stretching the knee joint, stretching the knee joint with valgus or abduction, stretching the knee joint with varus or adduction is suitable for patients with knee flexion and extension difficulty.Patellar manipulation by bending the knee 5-10 degrees downward is suitable for patients with patellar sliding difficulty.The lower end of the muscle length manipulation is suitable for patients with muscle tension and soft tissue tension.Soft tissue loosening is performed in the suprapatellar and peripatellar regions, medial and lateral capsule joints, and popliteal fossa.
    2. Activity training: Mainly about the knee joint flexion and extension movement training.
    3. Strength training: Mainly about quadriceps muscle resistance exercises

    This group receives 8 treatments over a 3 week period with a one week follow-up on site and a 3 month follow-up by mail, phone or email.

Study groups in NCT03966248
Study groupRoleWhat they receive
Chinese Tuina group (CTG)ExperimentalThe participants in CT group will receive the traditional Chinese Tuina therapy on the basis of KOA health education and home-exercise.
Receives: Other: Chinese Tuina therapy
Physical Manual group (PMG)Active comparatorThe participants in PM group will receive the modern physical manual therapy on the basis of KOA health education and home-exercise.
Receives: Other: Physical Manual therapy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Western Ontario and McMaster University Osteoarthritis Index (WOMAC)

    Self report measure of pain, stiffness, and physical function for people with knee osteoarthritis.

    Measured: Change from baseline at 4 weeks

Secondary outcomes (12)
  1. Change in Western Ontario and McMaster University Osteoarthritis Index (WOMAC)

    Self report measure of pain, stiffness, and physical function for people with knee osteoarthritis.

    Measured: Change from baseline at 8 weeks and 16 weeks

  2. Change in Numeric Knee Pain Rating Scale

    Subjects will rate their worst knee pain in the last 24 hours using an 11 point numeric pain rating scale with 0 representing "no pain" and 10 representing " the worst pain imaginable".

    Measured: Change from baseline at 4 weeks, 8 weeks and 16 weeks

  3. Change in Patient Global Assessment (PGA)

    The Patient global assessment rating is a 11 point Numeric Rating Scale in which subjects will rate the degree to which their knee condition has changed from the time treatment was initiated to the present. The subject responds to the following query: "Please rate your overall knee's condition from the time you began treatment until now." using an 11 point numeric rating scale with 0 representing "A very great deal better" and 10 representing "A very great deal worse".

    Measured: Change from baseline at 4 weeks, 8 weeks and 16 weeks

  4. Change in 12-item Short Form Health Survey (SF-12)

    The SF-12 is a generic health-related quality of life measure.

    Measured: Change from baseline at 4 weeks, 8 weeks and 16 weeks

  5. Change in 30 second time chair rise test

    Subjects will be seated with their arms crossed in front of their chest. On the command "go" subjects will stand up and sit down for as many trials as they can in a 30 second period.

    Measured: Change from baseline at 4 weeks

  6. Change in Timed Up and Go Test Time

    On the command "go" subjects will stand up from a chair, walk 3 meters, turn around, return to the chair and sit down. The time it takes to complete this task will be recorded.

    Measured: Change from baseline at 4 weeks

  7. Change in One Leg Standing Test

    One single-leg standing was assessed balance. Test required the subject to stand with arms by his/her side.Timing was started when the subject raised one foot off the ground. Timing was stopped if the subject displaced the weight-bearing foot, touched the suspended foot to the ground, used the suspended limb to support the weight-bearing limb, or reached the maximum balance time of 30 seconds.

    Measured: Change from baseline at 4 weeks

  8. OARSI Responder Criteria

    Responder criteria included 1) greater than or equal to 50% improvement in WOMAC pain or WOMAC function and an absolute improvement of greater than or equal to 20, or 2) improvement in at least 2 of the following 3 scores: 20% improvement in pain and absolute change ≥ 10 on WOMAC pain score, 20% improvement in pain and absolute change ≥ 10 on WOMAC function score, or moderate or greater improvement (≤ 4) on a 15 point global rating of change scale

    Measured: At weeks 4 after randomisation.

  9. Blinding assessment

    To test whether the participants are blinded successfully, all participants will be asked to guess which kind of treatment they received.

    Measured: At weeks 4 after randomisation.

  10. Credibility/Expectancy Questionnaire

    The credibility and expectancy of participants will be measured using the Credibility/Expectancy Questionnaire

    Measured: About 5 min after the first treatment

  11. Rescue medicine

    Any use of pain-killers will be ascertained.

    Measured: At weeks 4, 8 and 16 after randomisation.

  12. Adverse events

    Adverse Event Form

    Measured: At weeks 4 after randomisation.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 May 2019
  2. Study start19 Oct 2019
  3. Primary completion7 Oct 2021
  4. Study completion7 Oct 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Two arms recruit and evaluate the participants at the same time, and the included participants have the equal opportunity to either the Chinese Tuina or physical manual therapy groups.
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
140 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03966248
Sponsor's protocol ID
DZM-KY201906
Status last verified
Feb 2023
First submitted
26 May 2019
Last updated
8 Feb 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Ma P, Liu L, Li S, Cai M, Han S, Weng Z, Chen Q, Gao Y, Zhang L, Wu G, Yang X, Zhang Y, Li D, Liu C, Sun Y, Yan S, Wang X, Yu C. Comparative effectiveness of Tuina therapy versus manual physical therapy for knee osteoarthritis: a randomized controlled trial. BMC Complement Med Ther. 2025 Apr 8;25(1):128. doi: 10.1186/s12906-025-04850-w.

    PubMed 40200237

Questions about this trial

What is this clinical trial studying?

A study testing Chinese Tuina therapy and Physical Manual therapy in people with Osteoarthritis, Knee, run by Beijing University of Chinese Medicine at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 8 Feb 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Western Ontario and McMaster University Osteoarthritis Index (WOMAC) (time frame: Change from baseline at 4 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03966248, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Feb 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in